Rupture: Clinical Trials

3 trials for Rupture, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 3
Phase 21Terminated 1

Follow Rupture: new trials by email Literature Review of Rupture trials Research Report on Rupture

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease
FX006 Injection - Rotator Cuff Tears, Rotator Cuff Tendinitis
Phase 3TerminatedNorthwell Health402020-08-272026-11-04
The Impact of a Preoperative Nerve Block on the Consumption of Sevoflurane in Total Shoulder Arthroplasty
Ropivacaine, Dextrose - Rotator Cuff Injuries, Anesthesia; Functional
Phase 2 / Phase 3TerminatedUniversity of Alberta172019-08-012024-06-06
A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections
Doripenem, Meropenem placebo, Meropenem - Abscess, Intra-Abdominal, Abdominal Abscess
Phase 3TerminatedJanssen Research & Development, LLC412010-12-012014-07-15

Narrower conditions

Rotator Cuff Injuries (2)  ·  Abdomen, Acute (1)  ·  Abdominal Abscess (1)  ·  Abdominal Pain (1)  ·  Appendicitis (1)  ·  Ileus (1)  ·  Infections (1)  ·  Intestinal Perforation (1)  ·  Peritonitis (1)  ·  Shoulder Impingement Syndrome (1)

Broader conditions

Wounds and Injuries (3)  ·  Shoulder Injuries (2)  ·  Tendon Injuries (2)  ·  Abscess (1)  ·  Cecal Diseases (1)  ·  Digestive System Diseases (1)  ·  Gastroenteritis (1)  ·  Gastrointestinal Diseases (1)  ·  Intestinal Diseases (1)  ·  Intestinal Obstruction (1)  ·  Intraabdominal Infections (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neurologic Manifestations (1)

Interventions

Amoxicillin-Potassium Clavulanate Combination (1)  ·  Doripenem (1)  ·  FX006 (1)  ·  Glucose (1)  ·  Meropenem (1)  ·  Ropivacaine (1)

Sponsors

Janssen Research & Development, LLC (1)  ·  Northwell Health (1)  ·  University of Alberta (1)

Countries

United States (2)  ·  Argentina (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)  ·  Latvia (1)  ·  Lithuania (1)  ·  Panama (1)

Top investigators

Lora Pencheva, MD (1)  ·  Rakesh V Sondekoppam, MD (1)  ·  Russell Camhi (1)  ·  Vivian HY Ip, MD (1)

Results publications

PMID 29664865

NIH funding

2009 (1)